Taylor Dayne Lands Vegas Strip Residency 4 Years After Colon Cancer Fight

Taylor Dayne is bringing her decades of hits to the Las Vegas Strip. The multi-platinum pop star will launch a residency at Harrah's Las Vegas this November, a career milestone arriving four years after she was diagnosed with stage 2 colon cancer.

Titled Tell It to My Heart: The Taylor Dayne Experience, the show is scheduled for Nov. 24-25, Nov. 27-28, Dec. 29-31, 2026, and Jan. 3, 2027, according to Caesars Entertainment. Tickets went on sale July 31, and the residency represents a new chapter for Dayne on the Strip. As PIX11 reports, the singer is marking the fourth anniversary of her colon cancer diagnosis even as she prepares to headline this new production.

The show is built as a three-act production featuring a live band, choreography, and LED visuals, co-presented by Zen Elite Equestrian and Filthy, according to Ticketmaster's listing for the event. It will be staged exclusively for Harrah's Las Vegas, in the 544-seat Harrah's Showroom on the third floor of the property — an intimate venue that was part of a $200 million renovation completed in 2021, per TicketSmarter. Harrah's Las Vegas originally opened in 1973 as the Holiday Casino, and its showroom currently hosts other headliner residencies including Donny Osmond alongside tribute shows like MJ Live, per Caesars Entertainment.

A Catalog Built for the Big Stage

Dayne's residency draws on a catalog that produced seven consecutive Top 10 hits on the Billboard Hot 100 between 1987 and 1990, a run capped by her 1990 No. 1 ballad Love Will Lead You Back, written by Diane Warren, according to Stereogum. PIX11 notes that Dayne, known for songs including Tell It to My Heart, Love Will Lead You Back, and I'll Be Your Shelter, has sold over 75 million albums and singles worldwide.

Born Leslie Wunderman in New York in 1962, Dayne co-wrote Tina Turner's 1996 Top 40 hit Whatever You Want, starred in Elton John's Broadway musical Aida, and has earned three Grammy Award nominations across her career, per the Las Vegas Sun. Her reach has extended beyond the Strip this year as well — Hoodline previously reported that Dayne was set to headline Cambridge's Saints Feast, the 101st Feast of Saints Cosmas and Damian in East Cambridge, Massachusetts, running September 11-13.

A Health Battle Behind the Comeback

Dayne was diagnosed with stage 2 colon cancer in July 2022 during a routine semi-annual colonoscopy, according to the Moffitt Cancer Center. She underwent surgery that removed 10 inches of her colon and has remained cancer-free without needing chemotherapy or radiation; she had maintained bi-annual colonoscopies after doctors previously found benign polyps.

The recovery was not straightforward. Dayne suffered a severe post-operative infection that required a 20-day hospital stay and dropped her weight to 98 pounds, yet she continued performing live in Hawaii while fitted with a central intravenous PICC line, Parade reported. She has credited her fans and local support in Hawaii with helping her rediscover her sense of purpose during that stretch. PIX11 notes that Dayne has triumphed over colon cancer and now advocates for early detection, including making sure women understand that colon cancer affects them as well as men.

Why Her Advocacy Matters Now

Dayne's story lands amid a documented shift in who colorectal cancer is striking. The American Cancer Society projected 158,850 new colorectal cancer cases in the United States in 2026, and while incidence rates among adults 65 and older are falling, cases among adults under 50 have risen by nearly 3% annually since 2013. Colorectal cancer is now the leading cause of cancer-related death in U.S. adults under age 50, per the same report.

That trend helped drive a change in federal guidance: the U.S. Preventive Services Task Force lowered the recommended age to begin average-risk colorectal cancer screening from 50 to 45 in May 2021, according to the Centers for Disease Control and Prevention. Routine colonoscopies allow physicians to detect and remove precancerous polyps before they become cancer, the CDC notes — the same kind of routine screening that caught Dayne's diagnosis in time for treatment.